Medium Vessel Occlusion Stroke (MeVO): Clinical Trials

2 trials for Medium Vessel Occlusion Stroke (MeVO), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 31Not yet recruiting 1

Follow Medium Vessel Occlusion Stroke (MeVO): new trials by email Literature Review of Medium Vessel Occlusion Stroke (MeVO) trials Research Report on Medium Vessel Occlusion Stroke (MeVO)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravenous Thrombolysis, Endovascular Treatment, or Bridging Therapy for Medium Vessel Occlusion Stroke Within 24 Hours
Tenecteplase, Endovascular Treatment - Medium Vessel Occlusion Stroke (MeVO), Acute Ischemic Stroke
Phase 3Not yet recruitingThe First Affiliated Hospital of University of Science and Technology of China13952026-12-012026-11-12
SAIL-MEVO: Endovascular Treatment Versus Best Medical Therapy for Distal Vessel Occlusions
best medical therapy, Endovascular Treatment - Medium Vessel Occlusion Stroke (MeVO), Stroke Acute
Not applicableRecruitingHospital Universitari Vall d'Hebron Research Institute4202026-11-012026-11-04

Narrower conditions

Ischemic Stroke (2)  ·  Stroke (1)

Broader conditions

Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Nervous System Diseases (2)  ·  Vascular Diseases (2)  ·  Stroke (1)

Interventions

Tenecteplase (1)

Sponsors

Hospital Universitari Vall d'Hebron Research Institute (1)  ·  The First Affiliated Hospital of University of Science and Technology of China (1)

Countries

China (1)  ·  Spain (1)

Top investigators

Wei Hu, MD, PhD (1)